144 related articles for article (PubMed ID: 3579357)
1. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Vonderheid EC; Thompson R; Smiles KA; Lattanand A
Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
[TBL] [Abstract][Full Text] [Related]
2. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
3. Interferon therapy for condylomata acuminata.
Eron LJ; Judson F; Tucker S; Prawer S; Mills J; Murphy K; Hickey M; Rogers M; Flannigan S; Hien N
N Engl J Med; 1986 Oct; 315(17):1059-64. PubMed ID: 3531860
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
[TBL] [Abstract][Full Text] [Related]
6. Effect of intralesional alpha 2-interferon on actinic keratoses.
Edwards L; Levine N; Weidner M; Piepkorn M; Smiles K
Arch Dermatol; 1986 Jul; 122(7):779-82. PubMed ID: 3524471
[TBL] [Abstract][Full Text] [Related]
7. Intralesional interferon in the treatment of early mycosis fungoides.
Wolff JM; Zitelli JA; Rabin BS; Smiles KA; Abell E
J Am Acad Dermatol; 1985 Oct; 13(4):604-12. PubMed ID: 2934438
[TBL] [Abstract][Full Text] [Related]
8. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
9. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.
Vance JC; Bart BJ; Hansen RC; Reichman RC; McEwen C; Hatch KD; Berman B; Tanner DJ
Arch Dermatol; 1986 Mar; 122(3):272-7. PubMed ID: 3954392
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
[TBL] [Abstract][Full Text] [Related]
11. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
[TBL] [Abstract][Full Text] [Related]
12. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
13. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
[TBL] [Abstract][Full Text] [Related]
14. Alpha recombinant interferon in the treatment of mycosis fungoides (MF).
Tura S; Mazza P; Zinzani PL; Ghetti PL; Poletti G; Gherlinzoni F; Montagnani A; Criscuolo D
Haematologica; 1987; 72(4):337-40. PubMed ID: 3117634
[No Abstract] [Full Text] [Related]
15. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Kohn EC; Steis RG; Sausville EA; Veach SR; Stocker JL; Phelps R; Franco S; Longo DL; Bunn PA; Ihde DC
J Clin Oncol; 1990 Jan; 8(1):155-60. PubMed ID: 2295906
[TBL] [Abstract][Full Text] [Related]
16. A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-gamma and has been in complete remission for more than 6 years.
Horikoshi T; Onodera H; Eguchi H; Hanada N; Fukuzawa K; Takahashi M; Ishihara K; Ikeda S
Br J Dermatol; 1996 Jan; 134(1):130-3. PubMed ID: 8745899
[TBL] [Abstract][Full Text] [Related]
17. Intralesional interferon alfa-2b for the treatment of genital warts.
Welander CE; Homesley HD; Smiles KA; Peets EA
Am J Obstet Gynecol; 1990 Feb; 162(2):348-54. PubMed ID: 2155531
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasis.
Morhenn VB; Pregerson-Rodan K; Mullen RH; Wood GS; Nickoloff BJ; Sherwin SA; Farber EM
Arch Dermatol; 1987 Dec; 123(12):1633-7. PubMed ID: 3120650
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
20. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
